tiprankstipranks
Advertisement
Advertisement

CDNA Stock Latest News

William Blair health diagnostics analyst holds analyst/industry conference call
The FlyWilliam Blair health diagnostics analyst holds analyst/industry conference call
23h ago
GH
ABT
AI Models Turn Cautious on CareDx, Flagging Profitability and Reimbursement Risks
PremiumAI Analyst Ratings
AI Models Turn Cautious on CareDx, Flagging Profitability and Reimbursement Risks
11d ago
CDNA
CareDx Downgraded by AI Models as Profitability and Reimbursement Risks Weigh on Outlook
PremiumAI Analyst Ratings
CareDx Downgraded by AI Models as Profitability and Reimbursement Risks Weigh on Outlook
13d ago
CDNA
CareDx: Solid Near-Term Execution vs. Reimbursement Headwinds and Long-Dated Pipeline Upside Justify Hold Rating
PremiumRatings
CareDx: Solid Near-Term Execution vs. Reimbursement Headwinds and Long-Dated Pipeline Upside Justify Hold Rating
1M ago
CDNA
CareDx Earnings Call Highlights Growth Amid Reimbursement Risks
PremiumCompany Announcements
CareDx Earnings Call Highlights Growth Amid Reimbursement Risks
1M ago
CDNA
CareDx announces launch of VANTx
PremiumThe FlyCareDx announces launch of VANTx
1M ago
CDNA
CareDx: Strong Growth, Discounted Valuation, and Emerging Oncology Optionality Support Buy Rating
Premium
Ratings
CareDx: Strong Growth, Discounted Valuation, and Emerging Oncology Optionality Support Buy Rating
1M ago
CDNA
CareDx price target raised to $26 from $25 at BTIG
Premium
The Fly
CareDx price target raised to $26 from $25 at BTIG
1M ago
CDNA
CareDx: Conservative Revenue Upside Offset by Weaker Margins and Coverage Uncertainty Justifying Hold Rating
PremiumRatings
CareDx: Conservative Revenue Upside Offset by Weaker Margins and Coverage Uncertainty Justifying Hold Rating
2M ago
CDNA
CareDx CFO Nathan Smith steps down, COO Keith Kennedy to succeed
PremiumThe Fly
CareDx CFO Nathan Smith steps down, COO Keith Kennedy to succeed
2M ago
CDNA
CareDx Names New CFO Amid Strong Q4 2025 Results
PremiumCompany Announcements
CareDx Names New CFO Amid Strong Q4 2025 Results
2M ago
8K
CDNA
CareDx reports Q4 adjusted EPS 12c, consensus 23c
PremiumThe Fly
CareDx reports Q4 adjusted EPS 12c, consensus 23c
2M ago
CDNA
CareDx sees FY26 revenue $420M-$440M, consensus $417.67M
PremiumThe FlyCareDx sees FY26 revenue $420M-$440M, consensus $417.67M
2M ago
CDNA
CDNA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CDNA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
CDNA
CareDx: Solid Near-Term Beat but LCD Overhang and Reimbursement Uncertainty Justify Hold Rating
Premium
Ratings
CareDx: Solid Near-Term Beat but LCD Overhang and Reimbursement Uncertainty Justify Hold Rating
3M ago
CDNA
CareDx reports preliminary Q4 revenue $108M, consensus $102.58M
PremiumThe Fly
CareDx reports preliminary Q4 revenue $108M, consensus $102.58M
3M ago
CDNA
NeoGenomics CFO Jeff Sherman to retire, Abhishek Jain to succeed
PremiumThe Fly
NeoGenomics CFO Jeff Sherman to retire, Abhishek Jain to succeed
3M ago
NEO
CDNA
Craig-Hallum downgrades CareDx to Hold on less compelling risk-reward
PremiumThe Fly
Craig-Hallum downgrades CareDx to Hold on less compelling risk-reward
3M ago
CDNA
CareDx downgraded to Hold from Buy at Craig-Hallum
PremiumThe Fly
CareDx downgraded to Hold from Buy at Craig-Hallum
3M ago
CDNA
CareDx Wins Preliminary Court Approval for Derivative Settlement
PremiumCompany AnnouncementsCareDx Wins Preliminary Court Approval for Derivative Settlement
4M ago
8K
CDNA
CareDx price target raised to $18 from $14 at Wells Fargo
Premium
The Fly
CareDx price target raised to $18 from $14 at Wells Fargo
4M ago
CDNA
CareDx Inc. Reports Strong Q3 Earnings Growth
Premium
Company Announcements
CareDx Inc. Reports Strong Q3 Earnings Growth
5M ago
CDNA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >